Incyte, MorphoSys’ CAR-T rival tafasitamab approved in EUIncyte and MorphoSys’ antibody therapy tafasitamab has been approved in Europe, promising to provide a more convenient alternative Share XIncyte, MorphoSys’ CAR-T rival tafasitamab approved in EUhttps://pharmaphorum.com/news/incyte-morphosys-car-t-rival-tafasitamab-approved-in-eu/
